Hormone pellets are inserted as an extremely safe procedure. There is a small chance that women might experience a related problem, like bleeding, infection under the skin, or temporary discomfort. Below is a list of possible risks and side consequences that are related to hormones that make up the pellets. made up of.
Testosterone pellet insertion. The health risks associated with bioidentical testosterone therapy for women haven’t been identified. Any adverse health risks that you’ve heard about could be linked to an oral synthetic medicine known as methyltestosterone.
It is the sole FDA-authorized testosterone that is available to females within the US and a different substance than bioidentical testosterone. When the risk of disease associated with hormone therapy is discussed the authors often put the various “hormones” into one big heap, without recognizing the fact that synthetic formulas are usually far more potent, they aren’t biochemically similar to the other, or even similar to the natural hormones we have as well as affect differently on the body than the natural hormones we are accustomed to.
The latest research on bioidentical testosterone formulations for women has not revealed an increase in risk for cancer, cardiovascular disease, or any other serious illness. Numerous research studies suggest that non-oral bioidentical testosterone could protect breasts and also protect bones, the heart, and the brain.
Treatment with testosterone pellets is generally well tolerated. The majority of women have no adverse reactions. A few suffer from acne or facial hair and both are manageable by reducing the dosage or by a different method. Most women who suffer from these adverse effects choose to address the problem rather than decrease the dosage, a factor that shows their satisfaction with the advantages of testosterone therapy.
Estradiol. There’s been plenty of debate and apprehension over the treatment of estrogen. Risk-related concerns mostly resulted from a study in 2002 that was conducted by known as the Women’s Health Initiative (WHI) that reported a slight growth in breast cancer as well as cardiovascular risk. The study, however, examined only one type of hormone, which was a 100% synthetic product (Premarin+Provera) and which is not a bioidentical hormone formula. Furthermore, an in-depth examination of the WHI and subsequent studies have shown that the increased risk of heart attack was due to the reality that the subjects started hormone therapy by the late ’60s, long after the menopausal phase, and most likely with already developed coronary artery plaques. It is now accepted by experts that when estrogen therapy is started in the early stages, within a couple of years after menopausal change it can protect the cardiovascular system, decreasing the development of coronary plaques, decreasing inflammation, and reducing the risk of dying. Concerning breast cancer, the WHI patients with a higher rate were taking a tablet of synthesized estrogen (Premarin) and the synthetic hormone progestin (Provera). But, those who received estrogen but not progestin had less incidence of cancers in the breast. These and other studies show that the progestin synthetic ingredient (not an estrogen-based ingredient) that is the specific treatment for hormones was believed to be the main cause for the risk of breast cancer found Contrary to this bioidentical progesterone has not been associated with many health risks and is safe to use on its own or in conjunction together with biological estrogen.
Estradiol pellet therapy can be well-tolerated and safe. When it is first introduced, women complain of transient breast tenderness and swelling, that if they persist, is manageable with a reduction of dosage. Uterine bleeding is often an intermittent issue, but there are often easy solutions that are non-surgical to control this. Certain women experience an increase in fluid volume due to estradiol therapy. This is managed by reducing the dosage or taking diuretics with a moderate dose.
Consultation and Evaluation for Hormone Pellet Therapy
The completion of the woman’s Hormone Pellet Therapy consultation will comprise a complete discussion of the symptoms and analysis as well as a pelvic ultrasound within our facility, as well as the testing of a variety of labs for hormonal baseline levels and other laboratory tests that are appropriate. Hormone Pellets can be placed in the following visit, after the discussion of lab or ultrasound tests.
Fee for Hormone Pellet Therapy for Women
In general, health insurance plans will pay for lab tests and office visits to evaluate hormone-related symptoms. However, insurance cannot provide reimbursement for bioidentical hormone compounded pellets or the pellet-insertion procedure.
The cost to receive female hormone therapy (including the procedure and pellets) costs $365.00. It is around $3.00 each day based on the frequency at which the pellets need to be replaced (typically once every three to five months). If one takes into account the amount which could be saved by treatments for depression, sleep anxiety, anxiety, and diabetes, as well as osteoporosis and the benefits to relationship quality, quality of life and job performance, the expense of treatment with pellets, is definitely worth it.
